Research and Markets: Imaging Agents - 2011 Global Strategic Business Report

Research and Markets (http://www.researchandmarkets.com/research/de99c1/imaging_agents_g) has announced the addition of the "Imaging Agents - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Imaging Agents in US$ Million by the following product segments - Contrast Media (X-Ray, MRI, & Ultrasound), and Diagnostic Radiopharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report profiles 55 companies including many key and niche players such as AMAG Pharmaceuticals Inc., Bayer Schering Pharma AG, Bracco Group, Covidien, Cytogen Corp., Daiichi Sankyo Company Limited, Eisai Co., Ltd, GE Healthcare, Guerbet Group, and Lantheus Medical Imaging. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Key Topics Covered:

1. Introduction, Methodology & Product Definitions

2. Industry Overview

3. Market Trends & Issues

4. Competition

5. Technology Breakthroughs

6. Product Overview 7. a Segmental Review

8. Technology Dynamics

9. Product Launches

10. Recent Industry Activity

11. Corporate Activity in Recent Past - a Perspective Builder

12. Product Introductions in Recent Past - a Perspective Builder

13. Focus on Select Players 14. Global Market Perspective 15. National Market Perspectives

Competitive Landscape

Total Companies Profiled:

55 (including Divisions/Subsidiaries - 71)

Companies Mentioned:

• Abbott Laboratories (USA)
• Advanced Magnetics, Inc (USA)
• Alliance Pharmaceutical Corp (USA)
• Altana Pharma AG (Germany)
• Astellas Pharma, Inc (Japan)
• Berlex Laboratories, Inc (USA)
• Best Medical International (USA)
• Biogen Idec, Inc (USA)
• Biomerica, Inc (USA)
• Biomira, Inc (Canada)
• Boston Life Sciences, Inc (USA)
• Bracco SpA (Italy)
• Bristol-Myers Squibb Co (USA)
• Capintec, Inc (USA)
• Cardinal Health, Inc (USA)
• Certus International, Inc (USA)
• Cook Group, Inc (USA)
• Conmed Corporation (USA)
• Cytogen Corporation (USA)
• Daiichi Pharmaceutical Co, Ltd (Japan)
• Sankyo Co, Ltd (Japan)
• Dow Pharmaceutical Sciences (USA)
• Eisai Co, Ltd (Japan)
• Enzon Pharmaceuticals, Inc (USA)
• EPIX Pharmaceuticals (USA)
• E-Z-Em, Inc (USA)
• GE Healthcare (USA)
• Glenwood LLC (USA)
• Guerbet Group (France)
• Hanger Orthopedic Group, Inc (USA)
• Hans O Mahn & Co (Germany)
• ImaRx Therapeutics, Inc (USA)
• Immunomedics, Inc (USA)
• Iso-Tex Diagnostics, Inc (USA)
• King Pharmaceuticals, Inc (USA)
• MCI Australia Pty, Ltd (Australia)
• MDS Nordion (Canada)
• Medefield Pty, Ltd (Australia)
• Medi/Nuclear Corp, Inc (USA)
• Medimaging Technology, Inc (USA)
• MedImmune, Inc (USA)
• Med-Tec, Inc (USA)
• Missionpharma A S (Denmark)
• Neoprobe Corporation (USA)
• NeoRx Corporation (USA)
• Pharmacyclics, Inc (USA)
• Philips Medical Systems International BV (The Netherlands)
• Resolution Pharmaceuticals, Inc (Canada)
• Sanofi-Aventis (France)
• Schering AG (Germany)
• Sonus Pharmaceuticals, Inc (USA)
• Tyco Healthcare Group LP (USA)
• Ulrich GmbH & Co, KG (Germany)
• Upperton Ltd (UK)

For more information visit http://www.researchandmarkets.com/research/de99c1/imaging_agents_g